82397
HCPCS/CPT
Prior Authorization
No Prior Auth Required
Code is covered without prior authorization (high confidence)
Medicare Pricing
Work RVU
0.00
Facility
N/A
Non-Facility
N/A
Documentation Required
- No explicit documentation requirements are specified in this document chunk. (The policy references that histopathologic confirmation via biopsy is the gold standard in the background and cites studies where biopsy/histology was used as the reference standard.)
- Photographs and videos of oral lesions (study analyzed photographs and videos of 25 patients).
- Biopsy specimen(s) with histopathological analysis for any suspicious lesions identified (study performed biopsies with histopathological analysis on lesions examined with GOCCLES).
- Documentation of lesion(s) being clinically suspicious/OPMD and monitored for malignant transformation (context: OPMDs must be regularly monitored via clinical examination).
Key Coverage Criteria
- No specific "Covered Indications" section is provided in this document. No adjunctive oral screening devices, salivary tests, or imaging systems are described as covered in the text. (Conventional visual and tactile oral examination and histopathologic assessment by biopsy remain the clinical standard discussed in the background and evidence sections.)
- Adjunctive aid to clinicians in detecting and distinguishing between cancerous and benign oral mucosal lesions.
- Use to identify dysplastic areas in patients with oral potentially malignant disorders (OPMDs).
- Use to help distinguish OPMDs from healthy oral mucosa (simple, inexpensive, rapid, non-invasive procedure).
- Use as part of regular clinical monitoring of OPMDs to detect possible malignant transformation (adjunct to clinical examination).
- Visualization of at least one suspicious oral mucosa lesion for subsequent biopsy guidance (as performed in the referenced study: examined in white light, Afl with optical filter GOCCLES, toluidine blue staining and then biopsied).
4 Active Policies
AMBETTER-CG-Gastro-Disorders-NonCa-2025.1 — Concert Genetic Testing: Gastroenterologic Disorders (non-cancerous)
MED207.117 — Serological Testing for Inflammatory Bowel Disease (IBD)
AETNA-CPB-0760 — Oral Screening and Lesion Identification Systems
AETNA-CPB-0348 — Recurrent Pregnancy Loss
Related Codes
Have a follow-up question?
Ask Verity about documentation requirements, denial risks, or coverage in your state.